Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3921]

Building the capacity to research health in conflict settings

Dr Abdulkarim Ekzayez - King's College London, London, UK

Building the capacity to research health in conflict settings ( Dr Abdulkarim Ekzayez - King's College London, London, UK )

Editor's Choice for August 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for August 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

New important compounds for targeted and immunotherapies for lung cancer

Dr Christian Rolfo - Univeristy of Maryland, Baltimore, USA

New important compounds for targeted and immunotherapies for lung cancer ( Dr Christian Rolfo - Univeristy of Maryland, Baltimore, USA )

Updates from a range of lung cancer studies

Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA

Updates from a range of lung cancer studies ( Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA )

Five practice changing shifts in oncology

Dr Jack West - Swedish Cancer Institute, Seattle, USA

Five practice changing shifts in oncology ( Dr Jack West - Swedish Cancer Institute, Seattle, USA )

Treating myelodysplastic syndromes

Prof Hugo Fernandez - Moffitt Cancer Center, Tampa, USA

Treating myelodysplastic syndromes ( Prof Hugo Fernandez - Moffitt Cancer Center, Tampa, USA )

Updates on data and results from PROPHECY, PALOMA-3 and CHECKMATE-227

Ignacio Gil-Bazo - Clínica Universidad de Navarra, Pamplona, Spain

Updates on data and results from PROPHECY, PALOMA-3 and CHECKMATE-227 ( Ignacio Gil-Bazo - Clínica Universidad de Navarra, Pamplona, Spain )

Two important pancreatic studies: PRODIGE 24 and PREOPANC

Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA

Two important pancreatic studies: PRODIGE 24 and PREOPANC ( Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA )

Rare mutations in non small cell lung cancer

Dr Tom Stinchcombe - Duke Cancer Institute, Durham, USA

Rare mutations in non small cell lung cancer ( Dr Tom Stinchcombe - Duke Cancer Institute, Durham, USA )

The promise of immunotherapy in head and neck, and prostate cancer

Dr Luis Larrea - NISA, Valencia, Spain

The promise of immunotherapy in head and neck, and prostate cancer ( Dr Luis Larrea - NISA, Valencia, Spain )

Several important studies for lung cancer

Prof Luis Raez - Herbert Wertheim College of Medicine, Miami, USA

Several important studies for lung cancer ( Prof Luis Raez - Herbert Wertheim College of Medicine, Miami, USA )

The PERSEPHONE trial: 6 months and 12 months of trastuzumab in breast cancer

Prof Mariana Chavez-McGregor - University of Texas MD Anderson Cancer Center...

The PERSEPHONE trial: 6 months and 12 months of trastuzumab in breast cancer ( Prof Mariana Chavez-McGregor - University of Texas MD Anderson Cancer Center, Houston, USA )

More from ecancer